Cystic fibrosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
* Inhaled osmotic agent/ Hypertonic saline: Increase the airway fluid layer<ref name="pmid19393104">{{cite journal |vauthors=Ratjen FA |title=Cystic fibrosis: pathogenesis and future treatment strategies |journal=Respir Care |volume=54 |issue=5 |pages=595–605 |year=2009 |pmid=19393104 |doi= |url=}}</ref> | * Inhaled osmotic agent/ Hypertonic saline: Increase the airway fluid layer <ref name="pmid19393104">{{cite journal |vauthors=Ratjen FA |title=Cystic fibrosis: pathogenesis and future treatment strategies |journal=Respir Care |volume=54 |issue=5 |pages=595–605 |year=2009 |pmid=19393104 |doi= |url=}}</ref> | ||
* Dornase alfa [recombinant human deoxyribo-nuclease (DNase)]: Cleave the extracellular DNA and aid airway clearance (DNA significantly increases the viscosity of the sputum) | |||
==References== | ==References== | ||
Revision as of 21:09, 13 February 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis medical therapy |
|
Risk calculators and risk factors for Cystic fibrosis medical therapy |
Overview
Medical Therapy
- Inhaled osmotic agent/ Hypertonic saline: Increase the airway fluid layer [1]
- Dornase alfa [recombinant human deoxyribo-nuclease (DNase)]: Cleave the extracellular DNA and aid airway clearance (DNA significantly increases the viscosity of the sputum)